论文部分内容阅读
1上市药讯1．l抗肿届药物罗氏（Roche）公司的单克隆抗体ritux－imab刚a’3MllH）在瑞典上市（1998．10），用于治疗非何杰金淋巴瘤。该药是由ROCh公司与IDEC公司共同开发，已于1997年在瑞士及美国上市。Zeneca公司的雌激素桔抗剂他莫昔芬（tamoxifen，Nolvadex）在美国首次获
1 listed drug news 1. l The anti-tumor drug Roche’s monoclonal antibody rituximab is marketed in Sweden (1998.10) for the treatment of non-Hodgkin’s lymphoma. Developed jointly by ROCh and IDEC, the drug was launched in Switzerland and the United States in 1997. Zeneca’s estrogen antagonist tamoxifen (tamoxifen, Nolvadex) was first reported in the United States